Compositions for treating epithelial and retinal tissue diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 3, 2006
Issued Date -
N/A
app pub date -
Feb 27, 2002
filing date -
Aug 21, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to mononucleoside phosphate compounds that have the benefits of a dinucleotide pharmaceutical. These mononucleoside phosphates can be made from a mononucleotide that has been modified by attaching a degradation resistant substituent on the terminal phosphate of a polyphosphate mononucleotide. By attaching this degradation resistant substituent, the stability from degradation matches or exceeds those of certain dinucleotides.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully